Type 2 diabetes trials in Hungary
18 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Balatonfüred, Budapest XII, Budapest XIII, Budapest XXI, Debrecen, Szeged, Szekesfehervar
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Balatonfüred, Budapest VIII, Budapest XII, Budapest XIII, Debrecen, Szeged
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Taking peopleAMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
- Where
- Baja, Balatonfüred, Békéscsaba, Gyula, Kaposvár, Kecskemét, Nyíregyháza, Szeged
- Age
- 18 years and over
- People
- 595 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00 - Phase 3Taking peopleAMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
- Where
- Biatorbágy, Budapest XIII, Budapest XXI, Pécs, Szolnok
- Age
- 18 years and over
- People
- 245 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2026-525474-20-00 · EU 2026-525474-20-00 - Phase 3Taking peopleA Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Where
- Budapest, Budapest XII, Debrecen, Nyíregyháza, Szeged
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07843485 · EU 2026-526189-25-00 - Phase 3Not yet taking people in HungaryA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Balatonfüred, Budapest XII, Budapest XVII, Debrecen, Nagykanizsa, Nyíregyháza, Szeged
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Budapest III, Budapest VIII, Budapest XIII, Debrecen, Salgótarján, Szeged, Szolnok, Zalaegerszeg
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Baja, Békéscsaba, Budapest, Budapest VI, Budapest Viii, Budapest XIII, Budapest XVIII, Hatvan, Kaposvár, Komárom, Pécs, Szekszárd
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Balatonfüred, Budapest, Debrecen, Miskolc, Nyíregyháza-Sóstóhegy, Szeged, Szolnok
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - Phase 3Taking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Budapest III, Budapest VIII, Budapest XIII, Debrecen, Salgótarján, Szeged, Szolnok, Zalaegerszeg
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Budapest III, Budapest VIII, Budapest X, Pécs, Szeged
- Age
- 18 years to 75 years
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00 - Phase 3Taking peopleA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Baja, Bekescsaba, Békéscsaba, Biatorbágy, Budapest III, Budapest VIII, Budapest XIV, Nyíregyháza, Szeged, Szolnok
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Where
- Debrecen, Szeged
- Age
- 18 years to 75 years
- People
- 270 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Budapest, Debrecen, Dunaújváros, Szeged, Szolnok
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00 - No phaseTaking peopleA Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Where
- Budapest, Debrecen, Salgótarján, Szeged, Szolnok, Zalaegerszeg
- Age
- 18 years and over
- People
- 2,150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07606066 - No phaseTaking peopleHealth for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
- Where
- Balatonfüred, Békéscsaba, Budapest, Csorna, Debrecen, Encs, Győr, Gyula, Hatvan, Jászszentlászló, Kaposvár, Kecskemét, Miskolc, Nyíregyháza, Orosháza, Pécs, Sopron, Szeged, Székesfehérvár
- Age
- 40 years and over
- People
- 15,000
- Run by
- Center for Molecular Fingerprinting Research Nonprofit LLC
See details and how to joinNCT07743021 - No phaseNot yet taking people in HungaryInvestigation of the Effectiveness of Prophylactic NPWT (ciNPWT) in High-risk Diabetic Patients With Acute Laparotomy Wounds
- Where
- Budapest
- People
- 110
- Run by
- Semmelweis University
See details and how to joinNCT07392853 - No phaseTaking peopleCardiovascular Risk in Children With Chronic Conditions Study
- Where
- Budapest
- Age
- 6 years to 25 years
- People
- 300
- Run by
- Semmelweis University
See details and how to joinNCT07086989